Back to results
CompletedPhase 2

Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient

NCT00752596

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Research Site

Scottsdale, Arizona, United States

View on ClinicalTrials.gov
Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient — TrialFind